
Professor, UC San Diego Stroke Center. Stroke researcher. @UCSDNeuro @UCSDHealth #strokepractitioner #translationalstrokeresearch #antiplatelets
San Diego, CA
Joined February 2019
- Tweets1.3K
- Following314
- Followers381
- Likes4.4K
Congratulations Pooja Khatri on receiving the Stroke Council Award and highlighting how we have broken down silos to improve the lives of stroke patients 🧠
#ISC2026 @StrokeAHA_ASA
Dawn Meyer PhD,FNP-C,FAHA retweeted
FASTEST presented at #ISC26 showed that treatment with rfFVIIa within 2 hours, even in the MSU, resulted in no difference between groups. Reduction of hematoma expansion was seen however. Subgroups treated within 90 minutes or with a spot sign did show significant difference!
Dawn Meyer PhD,FNP-C,FAHA retweeted
Medical management insights following CREST-2 from primary prevention pioneer Dr. Cheryl Bushnell - including suggestion of future updates for 2024 prevention guidelines #ISC2026 @StrokeAHA_ASA
Dawn Meyer PhD,FNP-C,FAHA retweeted
What's New in IVT? Relative and Absolute Contraindications #ISC26 @StrokeAHA_ASA
Dawn Meyer PhD,FNP-C,FAHA retweeted
Replying to @StrokeAHA_ASA
@StrokeAHA_ASA #ISC26
What fun moderating The Mentorship Playbook by the Stroke Career Development Committee with @GhadaMohamedMD and Oluchi, under the leadership of Dr Romero and Dr Digs.
Fantastic insights & advice on effective mentorship relationships by a star studded panel
Dawn Meyer PhD,FNP-C,FAHA retweeted
Great talk on GLP-1 targeted therapies for stroke, cognition, & brain health. Takeaway is GLP-1s are beneficial in pts w/ prior stroke, T2DM, HTN with ⬇️ total stroke rate (16% RRR and NNT=200). GLP-1s showed no difference in preventing cognitive impairment. #ISC26 @StrokeAHA_ASA
Dawn Meyer PhD,FNP-C,FAHA retweeted
Data has spoken. Loudly.
Watchful waiting isn’t a treatment.
#EMBOLISE2 non-surgical cohort at #ISC26 shows ~2x reduction in the composite endpoint of surgical rescue, clinical deterioration, or poor outcome.
NNT = 9.
#MMA embolization with #Onyx > observation.
“Let’s just observe” is a choice, not neutrality.
Take a side with our patients.
#ISC26 @medtronic #SVIN26 @svinsociety @AHAScience
Congratulations Dr Kazunori Toyoda on receiving the Ralph Sacco Outstanding Stroke Mentor award and your incredible contributions to generations of stroke researchers & clinicians
#ISC2026 @StrokeAHA_ASA
Excellent discussion on the intersection of stroke & migraine with partners at @ahsheadache.
#ISC2026 @StrokeAHA_ASA
4
229
No benefit with addition of TNK to EVT in basilar artery occlusion in the ATTENTION LATE trial. Sharing results of "negative" trials is critical to understanding and building on knowledge gained!
#ISC2026 #negativeclinicaltrial #attentionlate @StrokeAHA_ASA
Dawn Meyer PhD,FNP-C,FAHA retweeted
Another push towards extended window TNK with results of OPTION trial showing improved excellent functional outcomes at 90d with 2.8% risk of sICH within 36h.
#ISC2026 @StrokeAHA_ASA
Dawn Meyer PhD,FNP-C,FAHA retweeted
Choice 2: thrombectomy vs thrombectomy +IA alteplase
👉🏻favors thrombectomy + alteplase (NNT 7)
👉🏻No diff in sICH
👉🏻Difference in death likely reflects low event rate in control group
#ISC26 @StrokeAHA_ASA
Dawn Meyer PhD,FNP-C,FAHA retweeted
Happening NOW at #ISC26. Elena presenting novel and methodologically rigorous data supporting anticoagulation benefit in certain ESUS patients based on phenotypic clusters.
Head to Room R06-R09 2/4 5pm-6pm to learn about AR & VR in stroke care🧠 @BrettCMeyerMD
#ISC2026 #americanstrokeassociation
1
55
Dawn Meyer PhD,FNP-C,FAHA retweeted
Dr. Angel Chamorro presents data from CHOICE-2 trial showing IA alteplase following EVT improved functional outcomes (mRS 0-1) and patient QOL measures as well as improved reperfusion on CTP at #ISC26 @StrokeAHA_ASA
Dawn Meyer PhD,FNP-C,FAHA retweeted
Opening welcome remarks from AHA CEO Nancy Brown at #ISC26! Sharing the new 2025 guidelines for early stroke management in both adult and pediatric patient populations
Dawn Meyer PhD,FNP-C,FAHA retweeted
Cracking the ICAD code by @DrRamiMorsi from @UChicago Neurology 🧠
Dawn Meyer PhD,FNP-C,FAHA retweeted
STAT 2.0 Abstract Poster! Swing by Poster Hall B to learn more. #ISC26
Dawn Meyer PhD,FNP-C,FAHA retweeted
We spent a decade perfecting recanalization.
CHOICE-2 reminds us outcomes don’t end at TICI 2b.
EVT alone: “We’re done here.”
EVT + IA tPA: “Let’s actually finish the job.”
mRS 0–1: 57.5% vs 42.9%
Absolute benefit 15%. p = 0.002
Microvascular no-reflow is real. CHOICE-2 just made it hard to ignore.
Dawn Meyer PhD,FNP-C,FAHA retweeted
FASTEST trail presented at @StrokeAHA_ASA #ISC26
Key takeaway: Radiological improvement but no clinical benefit







































